You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy

Article info

Article menu
Clinical/translational cancer immunotherapy
Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy

Authors

  • Katie M Campbell Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Maneesha Thaker Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Egmidio Medina Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Anusha Kalbasi Radiation Oncology, University of California, Los Angeles, Los Angeles, California, USA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Arun Singh Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Antoni Ribas Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California, USA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, USA Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, California, USA Parker Institute for Cancer Immunotherapy, San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Theodore Scott Nowicki Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, USA Pediatrics, Division of Pediatric Hematology/Oncology, University of California, Los Angeles, Los Angeles, California, USA Microbiology, Immunology, & Molecular Genetics, University of California, Los Angeles, Los Angeles, California, USA Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles

Citation

Campbell KM, Thaker M, Medina E, et al
Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy
Journal for ImmunoTherapy of Cancer 2022;10:e004190. doi: 10.1136/jitc-2021-004190
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.